A tracking number does not establish product quality
A delayed peptide medication shipment creates two practical problems: whether the prescribed treatment will be interrupted and whether the product remains suitable when it arrives. Handle them separately with the prescriber and dispensing pharmacy. For injectable GLP-1 drugs, FDA currently recommends not using a product that arrives warm or with insufficient refrigeration because its quality may be affected. [1]
For background, see Ozempic refrigeration requirements before applying a general claim to a particular product.
This is more specific than a seller’s general reassurance that a thawed ice pack is harmless. A public article cannot reconstruct the temperature history of your parcel. Do not use a laboratory heat experiment or another product’s label to overrule FDA’s current patient advice. Ask the pharmacy for a documented resolution tied to the exact medicine and shipment.
While the parcel is delayed
Contact the platform and the dispensing pharmacy with the order and tracking information. Ask whether the package has actually been handed to the carrier or only has a label created. Find out who is responsible for opening the carrier inquiry and whether another shipment is being arranged. Save the response and the promised next update.
At the same time, contact the prescriber if you may miss a scheduled administration. Do not improvise a catch-up schedule, take extra medicine or borrow another person’s prescription. A delayed order does not provide enough information to determine a safe restart plan. The clinician needs to know the product, your recent treatment history and how long the interruption may last.
Document arrival before discarding the packaging
Photograph the outer box, insulation, cooling materials, label and any temperature indicator. Record the delivery time and when you brought the parcel inside. Note visible damage or leakage without opening containers unnecessarily. These observations help the pharmacy investigate what happened. They do not by themselves establish whether the preparation is potent or sterile.
Keep the lot number and order details. A seller may handle the refund conversation while the pharmacy handles the product assessment. Ask both parties to identify their role rather than accepting repeated referrals with no decision. FDA explains that consumers using telehealth platforms may not know the compounder; the label and order record are important for identifying that source. [2]
If an injectable GLP-1 medicine arrives warm
Do not use it while the problem is unresolved. FDA’s current warning advises against using injectable GLP-1 drugs that arrive warm or inadequately refrigerated. [1] Contact the pharmacy promptly for replacement or return instructions and speak with the prescriber about treatment continuity. Putting a warm package into the refrigerator does not establish that the shipment was acceptable.
Do not assume that an approved brand’s permitted time out of refrigeration applies to a compounded preparation. Nor should a vendor’s statement about a different ingredient concentration or packaging be treated as evidence for your order. The relevant question is the specific finished product and its actual handling. A support reply should identify what is being replaced or assessed and what you should do next.
For other peptide products, get product-specific instructions
“Peptide” covers a broad group of products. A topical cream, an oral medicine and a sterile injection do not share one shipping rule. Ask the dispensing pharmacy for the storage and handling requirements for the exact preparation. Compounded medicines do not undergo FDA’s premarket review for safety, effectiveness and quality. [2] Do not manufacture a generic shelf-life promise from that uncertainty.
If the package is damaged, the instructions are missing or the label does not match the order, ask the pharmacy to resolve the discrepancy before use. Keep the product securely stored as instructed while awaiting that resolution. Avoid attempting a home potency test or judging sterility from appearance. A clear liquid is not evidence that a damaged shipment is safe.
Replacement, refund and reporting
Ask for the replacement timeline, whether another charge will occur and how the subscription will be adjusted if treatment is delayed. Shipping policies vary, so this guide cannot promise a free replacement or refund. Keep the written policy and your incident record together. If you are told the product is usable, ask for the exact written basis and a clinician’s guidance where needed.
If you suspect a quality problem, medication error or reaction, FDA’s MedWatch program provides a consumer reporting pathway. [3] Reporting is separate from requesting a refund and does not provide emergency care. A complete account includes the dispensing source, lot, arrival condition and any use or symptoms. Accurate details are more valuable than a general claim that the carrier ruined the medicine.
Continue comparing your options
See Ozempic refrigeration requirements for the related details and source material.
See Zepbound storage limits for the related details and source material.
See storage rules for the specific product for the related details and source material.